Annals of internal medicine
In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA1c at 52 wk.
Michael Tanner, ACP Journal Club Editorial Team at McMaster University
Published: 202510.7326/ANNALS-25-03845-JC
Abstract
CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].